Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lefamulin vs moxifloxacin in adult community-acquired bacterial pneumonia
CTR20191226Phase 3Completed
- Sponsor
- Lunsheng Pharma
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lefamulin in community acquired pneumonia (CAP), sponsored by Lunsheng Pharma. Started Oct 2019; status: completed.
02
Drugs
lefamulin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on CTR20191226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191226.